Lower prescription drug costs.

Jerrold Nadler · New York · Democratic

policy impact 3.00 specificity 1.00 extraction confidence 93%

Contest this claim

Occurrences

Jerry has led efforts to protect the health of mothers in the workplace through his landmark bill, the Pregnant Workers Fairness Act, introduced sweeping legislation to lower exorbitant prescription drug costs, battled extremist efforts to weaken birth control protections, and, of course, has worked tirelessly throughout the entirety of his career to protect women’s reproductive rights, including abortion.

Campaign page says Nadler introduced legislation to lower prescription drug costs.

Healthcare | Jerry Nadler for Congress
campaign · campaign_site · model gpt-5.4-mini

Evidence

"Pharmaceutical companies spend billions of dollars on ads that drive up the cost of their already expensive prescription drugs," said Representative Nadler. "The End Prescription Drug Ads Now Act will lower pharmaceutical drug prices for Americans by putting a stop to these wasteful ads..."

In July 2025, Nadler publicly introduced legislation explicitly intended to lower prescription drug prices by banning prescription drug advertising.

partial same_term A for effort

Representatives Nadler, Dexter, and Omar Introduce Bill to Ban Prescription Drug Ads | Congressman Jerry Nadler
secondary · model gpt-5.4-mini · confidence 93%

Contest this evidence item

"...the Independent Drug Value Assessment Act will help prevent corporate abuse and ensure that prices reflect the real value of drugs to patients, caregivers, and taxpayers."

Nadler has consistently sponsored bills aimed at reducing drug prices through pricing oversight and market discipline, showing concrete legislative effort on the issue.

partial same_term A for effort

Nadler, Porter Introduce Bill to Independently Value Drug Prices and Scrutinize Accelerated Approvals | Congressman Jerry Nadler
secondary · model gpt-5.4-mini · confidence 90%

Contest this evidence item

"...the introduction of a new bipartisan legislative package that will enhance efforts to lower prescription drug costs by taking on anticompetitive practices employed by large pharmaceutical companies."

Nadler previously advanced bipartisan legislation focused on generic-drug access and anti-competitive practices to lower prescription drug costs.

partial same_term A for effort

Bipartisan Legislative Package Introduced to Lower Prescription Drug Costs | Congressman Jerry Nadler
secondary · model gpt-5.4-mini · confidence 89%

Contest this evidence item

"Today, the House Judiciary Committee unanimously passed four bills to address prescription drug pricing..."

Nadler helped move multiple drug-pricing bills through committee, a concrete legislative step toward lowering prescription drug costs, though not final enactment shown here.

partial same_term A for effort

House Judiciary Unanimously Passes Bipartisan Bills to Lower Prescription Drug Prices | Congressman Jerry Nadler
secondary · model gpt-5.4-mini · confidence 88%

Contest this evidence item

"...introduced H.R. 2375... which will help lower prescription drug prices for Americans."

This is an earlier explicit legislative effort by Nadler to reduce drug prices by facilitating lower-cost generics and biosimilars.

partial same_term A for effort

Nadler & Collins Introduce Preserve Access to Affordable Generics and Biosimilars Act, Legislation to Lower Prescription Drug Prices | Congressman Jerry Nadler
secondary · model gpt-5.4-mini · confidence 87%

Contest this evidence item

"...House Republicans have abandoned their promise to lower costs for working families."

This shows Nadler continuing to frame lower costs, including health-care-related costs, as an active policy objective late in 2025; it does not prove enactment of a prescription-drug-cost policy.

unresolved same_term

Nadler Statement on Voting NO on GOP Funding Bill | Congressman Jerry Nadler
secondary · model gpt-5.4-mini · confidence 62%

Contest this evidence item

The report discusses prescription drug pricing reforms and notes savings from reducing the price of drugs such as Humira.

A House committee report in Nadler’s broader congressional sphere indicates continued federal attention to drug pricing, but it does not show that Nadler’s specific claim was fully delivered in the lookback window.

unresolved same_term

DRUG%20PRICING%20REPORT%20WITH%20APPENDIX%20v3.pdf
secondary · model gpt-5.4-mini · confidence 55%

Contest this evidence item

Assessments

partial same_term A for effort

The evidence shows Nadler repeatedly sponsored and advanced legislation explicitly aimed at lowering prescription drug costs, including generic/biosimilar competition bills, broader bipartisan anti-competitive-practices packages, and later drug-pricing reform proposals. He also helped move multiple bills through the House Judiciary Committee. However, the record provided does not show that Nadler secured final enactment of a policy clearly attributable to him that delivered the promised outcome in full during the relevant period. Because there is substantial documented legislative effort but no clear proof of full delivery, the best judgment is partial fulfillment rather than delivered.

provider openai · model gpt-5.4 · confidence 91%